Virologic and Serologic Outcomes of Mono Versus Dual HBV Therapy and Characterization of HIV/HBV Coinfection in a US Cohort

Abstract

While consistent trends toward increased HBV DNA suppression, HBeAg loss and HBeAb seroconversion were observed in Naive-DUAL compared with Naive-MONO, they were not statistically significant. Overall, HDV coinfection was low.